Physician profile
Errol Singh
NPI 1629141577
$8,122.96
in general payments reported to CMS, 2019-2025
15 companies · $50.00 in 2025
The $50.00 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.66 · 2021: $443 · 2022: $150 · 2024: $7,430 · 2025: $50.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,345 · Food and Beverage: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,345.28 |
| Food and Beverage | $1,135.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $3,826.06 | 2024 | Aquabeam System |
| Edap Technomed INC | $3,540.00 | 2024 | |
| Astellas Pharma US INC | $178.31 | 2020-2024 | |
| Teleflex LLC | $168.12 | 2021 | |
| Medtronic, INC. | $118.67 | 2022 | |
| Myovant Sciences INC. | $100.57 | 2021 | |
| Myriad Genetic Laboratories, INC. | $50.00 | 2025 | Prolaris |
| Pfizer INC. | $33.06 | 2021-2022 | |
| Ambu INC. | $21.63 | 2021 | |
| Abbvie INC. | $21.05 | 2024 | |
| Alexion Pharmaceuticals, INC. | $19.32 | 2022 | |
| Neotract INC. | $18.55 | 2020 | |
| Endo Pharmaceuticals INC. | $16.55 | 2021 | |
| Agiliti Surgical, INC. | $11.07 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,399.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Errol Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.